Analystreport

Jounce Therapeutics, Inc. (NASDAQ: JNCE) had its "buy" rating re-affirmed by analysts at Robert W. Baird.

Jounce Therapeutics, Inc.  (JNCE) 
Last jounce therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.jouncetx.com